Parcel Health
Sustainable prescription packaging, including the regulatory-compliant paper-based Tully Tube pill bottle.
Website: https://www.parcelhealth.co/
Cover Block
From the public record
| Field | Value |
|---|---|
| Name | Parcel Health |
| Tagline | Sustainable prescription packaging, including the regulatory-compliant paper-based Tully Tube pill bottle [Parcel Health, retrieved 2024] |
| Headquarters | Pittsburgh, United States [Innovation Works, July 2026] |
| Founded | 2019 [University of Michigan College of Pharmacy, February 2025] |
| Stage | Seed [Ben Franklin Technology Partners, June 2026] |
| Business Model | B2B |
| Industry | Healthtech |
| Technology | Hardware |
| Geography | North America |
| Growth Profile | Venture Scale |
| Founding Team | Co-Founders (2): Melinda Su-En Lee, Mallory Barrett [University of Michigan College of Pharmacy, February 2025]; [LinkedIn, retrieved 2026] |
| Funding Label | Seed |
| Total Disclosed | Approximately $1,500,000 [Ben Franklin Technology Partners, June 2026] |
Links
From the public record
- Website: https://www.parcelhealth.co/
The Short Version
PUBLIC Parcel Health makes sustainable prescription packaging for pharmacies and health systems, and it merits attention now because it is trying to replace a large, regulated, high-frequency product category with a paper-based alternative that has begun to move from pilots into real health-system deployments [Technical.ly, January 2022] [Innovation Works, July 2026] [McLaren Health Care News]. Founded in 2019 in connection with Melinda Su-En Lee's time at the University of Michigan College of Pharmacy, the company emerged from an earlier packaging concept, Phill Box, and later launched Tully Tube in late 2024 as a paper-based prescription vial aimed at pharmacy use cases [University of Michigan College of Pharmacy, February 2025] [Ben Franklin Technology Partners, June 2026]. The product case rests less on software novelty than on regulated packaging performance: Parcel Health positions Tully Tube as automation-ready and recyclable, while third-party coverage indicates it has been tested for compatibility with modern pharmacy workflows and adopted system-wide by the Barbara Ann Karmanos Cancer Institute after a pilot [Parcel Health, retrieved 2024] [Newswire] [McLaren Health Care News].
The team's relevance is straightforward, if still early: Lee is a PharmD-trained co-founder and CEO, and Mallory Barrett serves as co-founder and president, giving the company a combination of pharmacy-domain grounding and product orientation according to university and LinkedIn records [University of Michigan College of Pharmacy, February 2025] [LinkedIn, retrieved 2026]. Parcel Health sells on a B2B basis to pharmacies, hospital health systems, telemedicine companies, and medication-delivery businesses, a customer mix that can support both institutional pilots and lighter-weight direct purchase channels if conversion holds [Parcel Health, retrieved 2024] [Ben Franklin Technology Partners, June 2026]. On capital formation, the public record supports at least $577,000 of specifically identified funding and awards, including $430,000 from Innovation Works-related vehicles and a $125,000 UpPrize award, while company-linked and profile sources describe roughly $1.5 million in total disclosed funding overall [Innovation Works, July 2026] [Ben Franklin Technology Partners, June 2026] [University of Michigan College of Pharmacy, February 2025].
The near-term question is not whether the environmental problem exists, it plainly does, but whether Parcel Health can convert pilots and early adopters into repeatable, scaled procurement across health systems without losing the regulatory and operational advantages that define the product [Technical.ly, January 2022] [Innovation Works, July 2026]. Public signals are encouraging, including reported traction with more than 11 health systems in under 18 months after launch and a planned Wellstar pilot targeting at least 30,000 containers beginning in August 2025, but investors should watch closely for evidence of multi-site expansion, manufacturing consistency, and broader customer concentration disclosure over the next 12 to 18 months [Innovation Works, July 2026] [Signalbase] [Perplexity Sonar Pro Brief, August 2025].
Unconfirmed -- This section uses a mix of independent coverage, company materials, LinkedIn profiles, and one search-wrapper brief for some material claims, with several product and traction details lacking full independent corroboration.
Taxonomy Snapshot
| Axis | Value |
|---|---|
| Stage | Seed |
| Business Model | B2B |
| Industry / Vertical | Healthtech |
| Technology Type | Hardware |
| Geography | North America |
| Growth Profile | Venture Scale |
| Founding Team | Co-Founders (2) |
| Funding | Seed, total disclosed approximately $1,500,000 |
The Company in Brief
PUBLIC
Parcel Health presents as a Pittsburgh company built around a narrow but tangible operating problem: how pharmacies dispense medication without defaulting to single-use plastic packaging. The company says it was founded in 2019 and is headquartered in Pittsburgh, and its public site positions the business around sustainable prescription packaging for pharmacies and health systems [Parcel Health, retrieved 2024]. University of Michigan coverage ties the founding to Melinda Su-En Lee's PharmD studies and states that she co-founded Parcel Health in 2019 while at the College of Pharmacy [University of Michigan College of Pharmacy, February 2025].
The public record shows a fairly clear product and company progression. Parcel Health was named to AlphaLab Health's second cohort in December 2021, which placed the company inside Pittsburgh's health startup ecosystem early in its development [Innovation Works, December 2021]. By 2022, regional coverage described its earlier Phill Box packaging product and framed the company around reducing prescription-packaging waste [Technical.ly, January 2022] [Technical.ly, September 2022]. Parcel Health's later milestone was the late-2024 launch of Tully Tube, described by Ben Franklin Technology Partners as a paper-based pill bottle made for pharmacies, followed by early 2025 university-linked award funding and a July 2026 Innovation Works profile pointing to broader health-system traction [Ben Franklin Technology Partners, June 2026] [University of Michigan College of Pharmacy, February 2025] [Innovation Works, July 2026].
Single-source, plausible -- Confirmed in part by the company website and University of Michigan coverage, with milestone chronology supplemented by Innovation Works and Technical.ly.
What They Have Built
MIXED
The product story is fairly concrete, even if the technical stack is not. Parcel Health publicly centers its offering on Tully Tube, a paper-based prescription container designed for pharmacy use, with the company and regional backers describing it as regulatory-compliant and built to meet child-resistance requirements for U.S. dispensing contexts [Parcel Health, retrieved 2024] [Ben Franklin Technology Partners, June 2026]. The company launched Tully Tube in late 2024, according to Ben Franklin Technology Partners, after earlier work on Phill Box, a plastic-free prescription package described in prior coverage as recyclable, compostable, and biodegradable [Ben Franklin Technology Partners, June 2026] [NextPittsburgh, December 2021] [Technical.ly, September 2022].
The evidence on functionality points less to consumer novelty than to pharmacy workflow fit. Parcel Health says Tully Tube is automation-ready and recyclable, while third-party coverage says the product is undergoing automation testing and has characteristics that appeal to mail-order and compounding pharmacies [Parcel Health, retrieved 2024] [Newswire]. A separate founding account states the company developed Tully Tube after pharmacists asked for a more automation-friendly format, and that the design uses 53% less plastic, although that specific reduction figure appears in a single source and should be treated cautiously [pagetsitdone.com, retrieved 2026].
Parcel Health also appears to be broadening the packaging layer around the core container. Its website describes custom packaging tailored to brand needs and a product called Parcel Prompts, which it presents as a way to improve the patient experience, though the public material reviewed here does not provide enough technical detail to assess implementation or defensibility beyond packaging design and workflow compatibility [Parcel Health, Inc, retrieved 2024]. The strongest public proof of product readiness is deployment rather than specification: McLaren Health Care News reported that the Barbara Ann Karmanos Cancer Institute adopted Tully Tube as its standard prescription vial across pharmacy operations in Detroit and Farmington Hills after a pilot, replacing single-use plastic bottles system-wide at both locations [McLaren Health Care News, retrieved 2026].
Unconfirmed -- This section relies materially on company website claims and lightly corroborated press coverage, with one independently reported deployment at Karmanos and partial support from Ben Franklin Technology Partners and NextPittsburgh.
Market Size and Demand
From the public record
Prescription packaging is a small line item in pharmacy operations until regulation, waste reduction, and automation constraints force it into the foreground, which is why this market is becoming more investable now than its historical profile would suggest. The cleanest public demand signal in the record is not a formal TAM model, because no named third-party market-sizing report was provided, but rather the scale of the problem Parcel Health is targeting: more than 8 billion plastic prescription bottles are used annually in the U.S. [Technical.ly, January 2022]. That figure is an analogous market anchor rather than a revenue estimate, but it does establish a very large unit-volume substrate for any compliant replacement format. Public company and institutional materials also show that the buyer set spans pharmacies, hospital health systems, telemedicine companies, and medication-delivery businesses, which broadens the reachable market beyond a single dispensing channel [Parcel Health, retrieved 2024] [Innovation Works, July 2026].
The table below keeps to sizing and demand claims that appear in the cited record.
| Market signal | Figure | Relevance |
|---|---|---|
| U.S. plastic prescription bottles used annually | More than 8 billion | Indicates the replacement category is high-volume even before expanding to adjacent packaging formats [Technical.ly, January 2022] |
| Health systems reached by Parcel Health fewer than 18 months after launch | More than 11 | Suggests enterprise demand can form quickly if the product clears pharmacy workflow and compliance hurdles [Innovation Works, July 2026] |
| Telemedicine brands reported as direct-purchase customers | More than 20 | Points to an e-pharmacy and direct-to-consumer dispensing adjacency, though company-linked sourcing makes this less certain [Signalbase] |
| Wellstar Kennestone pilot target | At least 30,000 containers | Shows that even a single-site pilot can represent meaningful recurring unit demand [Ben Franklin Technology Partners, June 2026] |
The pattern here is straightforward. The available numbers support a large unit market and early evidence of institutional pull, but they do not yet support a precise public TAM, SAM, or SOM build.
Demand drivers are visible in the operating context. One is sustainability pressure, because the incumbent format is single-use plastic at very large scale [Technical.ly, January 2022]. Another is workflow compatibility: the company and supporting coverage repeatedly frame Tully Tube around regulatory compliance, child-resistance, and automation readiness, which implies buyers are unlikely to switch for environmental reasons alone unless the package also works inside existing pharmacy processes [Ben Franklin Technology Partners, June 2026] [Newswire]. A third tailwind is the rise of nontraditional dispensing channels. Reported adoption by telemedicine brands and the product's stated fit for mail-order and compounding pharmacies suggest demand is no longer limited to the retail counter, and that newer medication-delivery models may be more willing to trial alternative packaging if it supports brand presentation and shipping needs [Signalbase] [Newswire] [Parcel Health, Inc, retrieved 2024].
The adjacent markets are material because the packaging decision can travel with the prescription across settings. Hospital outpatient pharmacies and integrated health systems are one adjacency, supported by reported deployments or pilots involving Allegheny Health Network, Wellstar, Dartmouth Health, UVA Health, and Karmanos Cancer Institute coverage [Innovation Works, July 2026] [McLaren Health Care News]. Telemedicine and medication-delivery businesses form another, with HelloCake and Good Life Meds named in supporting coverage as adopters in that channel [Ben Franklin Technology Partners, June 2026]. The substitute set is still dominated by incumbent plastic prescription bottles and other conventional pharmacy packaging, even if those alternatives are not named individually in the sourced material. That matters because replacement decisions in packaging are usually governed by procurement, pharmacy operations, and compliance, not just consumer preference.
Regulation is the main market gatekeeper. The repeated emphasis on regulatory-compliant and child-resistant packaging indicates that this category is constrained by pharmacy and patient-safety requirements before it is constrained by brand demand [Ben Franklin Technology Partners, June 2026] [Parcel Health, retrieved 2024]. Macro conditions also help explain timing: health systems and pharmacy operators are under cost, labor, and sustainability scrutiny at once, which tends to favor products that can fit existing automation and reduce environmental burden without asking buyers to redesign core dispensing workflows [Innovation Works, July 2026]. The current evidence supports a credible niche within healthcare packaging, with upside if compliant paper-based containers can move from pilots and specialty use cases into routine dispensing volume.
Single-source, plausible -- Section relies on one independent analogous market statistic from Technical.ly and several company-linked or ecosystem-publisher adoption signals from Innovation Works, Ben Franklin Technology Partners, Parcel Health, and Signalbase.
Who Else Is Fighting for This
MIXED Parcel Health is not competing against a dense field of named paper-based pharmacy vial startups in the public record so much as it is trying to displace entrenched plastic prescription packaging and the operational habits built around it [Technical.ly, January 2022] [Parcel Health, retrieved 2024].
The competitive map is clearest when separated by buyer workflow rather than by startup category. For retail pharmacies, hospital outpatient pharmacies, and mail-order operators, the default incumbent remains the standard plastic prescription bottle and its associated supply chain, which benefits from familiarity, established automation compatibility, and low switching friction, even if the environmental profile is poor [Technical.ly, January 2022]. Against that, Parcel Health is positioning Tully Tube as a regulatory-compliant paper-based alternative designed specifically for pharmacy use, while its earlier Phill Box appears to have served as a lighter-weight entry point for sustainable medication packaging before the current vial-format push [Ben Franklin Technology Partners, June 2026] [NextPittsburgh, December 2021]. Adjacent substitutes also matter. Custom branded packaging vendors can serve telemedicine and direct-to-patient medication brands on experience and presentation, even if they are not purpose-built to replace the standard pharmacy vial at scale [Parcel Health, Inc, retrieved 2024].
Parcel Health's edge today appears to come from product specificity and early channel validation, not from scale. Public sources point to more than 11 health systems nationwide within 18 months of launch, plus more than 20 telemedicine brands as direct-purchase customers, although the telemedicine figure rests on weaker sourcing and should be treated cautiously [Innovation Works, July 2026] [Signalbase]. More important than the raw count is the nature of the reference base: Karmanos Cancer Institute rolled out Tully Tube as its standard prescription vial across pharmacy operations in Detroit and Farmington Hills after a pilot, and Wellstar's Kennestone retail pharmacy committed to a pilot targeting at least 30,000 containers beginning in August 2025 [McLaren Health Care News] [Perplexity Sonar Pro Brief, August 2025]. That gives Parcel Health a credible regulatory and workflow story with institutional buyers. The durability of that edge is less settled. If the differentiation rests on being first to a compliant paper-based format, it is durable only so long as larger packaging manufacturers do not replicate the format and underprice distribution. If, instead, the advantage is embedded know-how around child resistance, pharmacy automation, and buyer trust, the position could last longer, but the public record does not yet establish proprietary barriers beyond early execution [Ben Franklin Technology Partners, June 2026] [Newswire].
The exposure is straightforward. Parcel Health does not appear, from the cited public evidence, to control a dominant distribution channel, a major health-system procurement network, or a capital base that would let it outspend established packaging suppliers if the category proves attractive [Innovation Works, July 2026] [Ben Franklin Technology Partners, June 2026]. It is also still proving compatibility rather than closing that debate entirely. Newswire-described automation testing supports the claim that Tully Tube is built for modern pharmacy systems, but ongoing testing is not the same thing as category-wide operational acceptance [Newswire]. The company is therefore most vulnerable where buyers prioritize proven throughput, lowest unit cost, and incumbent vendor relationships over sustainability goals. Telemedicine and medication-delivery brands may be a more open flank because packaging can function as part of the patient experience, but those channels can also be served by broader custom-packaging providers with deeper fulfillment relationships [Parcel Health, Inc, retrieved 2024].
The most plausible 18-month scenario is not a winner-take-all market, but a split one. Parcel Health is the likely winner if health systems continue to treat sustainable pharmacy packaging as a procurement priority and if pilots keep converting into standard-vial deployments, as Karmanos did system-wide [McLaren Health Care News]. The likely loser in that case is the legacy single-use plastic bottle within oncology, specialty pharmacy, and brand-sensitive direct-to-patient channels, where sustainability and patient experience carry more weight than they do in commodity dispensing [Technical.ly, January 2022] [Ben Franklin Technology Partners, June 2026]. The reverse scenario is also plausible. If automation validation stalls or if scaled incumbents introduce comparable paper-based or lower-plastic formats through existing pharmacy supply contracts, Parcel Health's first-mover narrative becomes more perishable, and the winner is the incumbent packaging ecosystem rather than a named startup challenger [Newswire] [Innovation Works, July 2026].
Single-source, plausible -- Based primarily on company, accelerator, and regional publisher coverage, with strong corroboration for selected deployments but no named startup competitor set in the structured public sources.
Opportunity
PUBLIC
The prize here is not a better pharmacy accessory, but a credible shot at becoming the default sustainable container standard for a category that still runs on billions of disposable plastic vials each year in the U.S. [Technical.ly, January 2022].
The headline opportunity is straightforward. If Parcel Health can prove that a paper-based prescription container can meet pharmacy workflow, child-resistance, and deployment requirements at health-system scale, it could become the replacement layer for a large, routine, and regulation-constrained packaging category that incumbents have treated as static for decades [Ben Franklin Technology Partners, June 2026] [Innovation Works, July 2026]. That outcome looks reachable, not merely aspirational, because the company has moved beyond concept-stage language into real deployments and named institutional adoption: Innovation Works reported more than 11 health systems nationwide fewer than 18 months after launch, and McLaren Health Care News reported that the Barbara Ann Karmanos Cancer Institute rolled out Tully Tube as its standard prescription vial across pharmacy operations in Detroit and Farmington Hills after a pilot [Innovation Works, July 2026] [McLaren Health Care News, retrieved 2026].
A second reason the upside matters is that the product sits inside a purchasing motion with unusually high repetition. Prescription packaging is not bought once, it is reordered continuously, and Parcel Health is selling into buyers that already process large medication volumes, including pharmacies, hospital health systems, telemedicine companies, and medication-delivery businesses [Parcel Health, retrieved 2024] [Ben Franklin Technology Partners, June 2026]. If the company becomes trusted for one format, the move from pilot to standard packaging line can produce durable reorder revenue rather than one-off project income.
| Scenario | What happens | Catalyst | Why it's plausible |
|---|---|---|---|
| Health-system standardization | Parcel Health turns pilots into system-wide packaging replacements across hospitals and retail pharmacy networks | A visible system-wide conversion similar to Karmanos, where Tully Tube replaced single-use plastic bottles across both pharmacy locations after a successful pilot [McLaren Health Care News, retrieved 2026] | The company already worked with more than 11 health systems nationwide, according to Innovation Works, suggesting it has crossed from design interest into operational buying conversations [Innovation Works, July 2026] |
| Telemedicine default supplier | Parcel Health becomes the preferred packaging vendor for digitally native pharmacy and medication-delivery brands | Expansion from the reported base of more than 20 telemedicine brands and proof that branded, sustainable packaging improves retention or brand economics [Signalbase, retrieved 2026] [Parcel Health, Inc, retrieved 2024] | Ben Franklin Technology Partners named HelloCake and Good Life Meds among telemedicine adopters, and the company offers custom packaging tailored for brands, which fits the economics of direct-to-consumer medication businesses [Ben Franklin Technology Partners, June 2026] [Parcel Health, Inc, retrieved 2024] |
| Category standard setter | Tully Tube becomes the reference product for sustainable, automation-compatible prescription packaging in pharmacy operations | Successful automation validation and additional named deployments at scaled pharmacy operators [Newswire] [Innovation Works, July 2026] | Parcel Health launched Tully Tube in late 2024, described it as automation-ready on its site, and third-party coverage said it was undergoing rigorous automation testing, which is the gating requirement for broader workflow adoption [Ben Franklin Technology Partners, June 2026] [Parcel Health, retrieved 2024] [Newswire] |
The compounding mechanism is operational rather than social. One health-system win can validate regulatory fit, workflow compatibility, and procurement credibility for the next buyer, especially in a category where packaging changes touch compliance, automation, and patient experience at the same time [Innovation Works, July 2026] [McLaren Health Care News, retrieved 2026]. The available evidence suggests that flywheel may already be forming: AlphaLab Health appears to have helped open an early Allegheny Health Network relationship, Innovation Works later reported growth to more than 11 health systems, and named telemedicine customers indicate the product is not confined to a single channel [Innovation Works, December 2021] [Innovation Works, July 2026] [Ben Franklin Technology Partners, June 2026].
There is also a product-line compounding path. Parcel Health started with Phill Box and then introduced Tully Tube after pharmacists asked for an automation-friendly option, according to Paget's business profile coverage, which implies customer feedback is shaping a broader packaging portfolio rather than a single SKU bet [pagetsitdone.com, retrieved 2026]. In practical terms, that means every account won for one packaging need can become an opening for adjacent formats, custom packaging, or branded patient-facing inserts such as Parcel Prompts, deepening account value over time [Parcel Health, Inc, retrieved 2024].
The size of the win is easiest to frame through category share rather than a hard valuation claim. The U.S. uses more than 8 billion plastic prescription bottles annually, according to Technical.ly, so even a low-single-digit conversion of that unit volume would imply a substantial packaging business if Parcel Health becomes a standard alternative in health systems and mail-order pharmacy [Technical.ly, January 2022]. A 1 percent share of that bottle volume would equal roughly 80 million containers annually (scenario, not a forecast), and the reported Kennestone pilot alone targeted at least 30,000 containers beginning in August 2025, which helps anchor the idea that volume can scale meaningfully account by account rather than only through national contracts [Perplexity Sonar Pro Brief, August 2025] [Technical.ly, January 2022].
The conservative read is that this remains an early execution story with sparse public financial disclosure. The optimistic read, and the reason the opportunity is worth attention, is that Parcel Health is trying to replace a consumable embedded in everyday care delivery, and the early public evidence shows real institutions are willing to test and, in at least one documented case, standardize around that proposition [McLaren Health Care News, retrieved 2026] [Innovation Works, July 2026].
Single-source, plausible -- This section relies on a mix of independent regional and institutional sources, including Technical.ly, Innovation Works, Ben Franklin Technology Partners, and McLaren Health Care News, but some product and pilot detail remains supported by single-source or company-adjacent reporting.
Sources
From the public record
[Parcel Health, retrieved 2024] Parcel Health Sustainable Prescription Packaging | https://www.parcelhealth.co/
[Innovation Works, July 2026] Parcel Health Reimagines Medication Delivery | https://www.innovationworks.org/case-studies/parcel-health-reimagines-medication-delivery/
[University of Michigan College of Pharmacy, February 2025] Pharmacy Student Co-founds Sustainable Medication Packaging Company; Awarded Seed Funding | https://pharmacy.umich.edu/news/pharmacy-student-co-founds-sustainable-medication-packaging-company-awarded-seed-funding/
[Ben Franklin Technology Partners, June 2026] Parcel Health | https://benfranklin.org/company_spotlight/parcel-health/
[LinkedIn, retrieved 2026] Melinda Su-En Lee - Parcel Health, Inc | LinkedIn | https://www.linkedin.com/in/melindasuenlee/
[LinkedIn, retrieved 2026] Mallory Barrett - Parcel Health, Inc | LinkedIn | https://www.linkedin.com/in/mallory-barrett-b02887126/
[Technical.ly, January 2022] RealLIST Startups: These are Pittsburghs top 10 standout | https://technical.ly/startups/pittsburgh-reallist-startups-2022/
[McLaren Health Care News, retrieved 2026] Karmanos Cancer Institute rolls out Tully Tube as standard prescription vial across pharmacy operations | https://www.mclaren.org/main/news/karmanos-cancer-institute-rolls-out-tully-tube-as-standard-prescription-vial-across-pharmacy-operations-5962
[Technical.ly, September 2022] Pittsburghs RealLIST Startups: So far, these founders say 2022 has | https://technical.ly/startups/pittsburghs-reallist-2022-update/
[Innovation Works, December 2021] AlphaLab Health Second Cohort of Startups Press Release | https://www.innovationworks.org/about/news/alpha-lab-health-announces-second-cohort-of-startups-accepted-to-life-science-accelerator/
[NextPittsburgh, December 2021] 6 AlphaLab Health startups could change the way you look at medicine | https://nextpittsburgh.com/latest-news/6-alphalab-health-startups-could-change-the-way-you-look-at-medicine/
[Parcel Health, Inc, retrieved 2024] Parcel Health | https://www.parcelhealth.co/
[Newswire] Parcel Health advances automation testing for Tully Tube | https://www.newswire.com/news/parcel-health-advances-automation-testing-for-tully-tube-22502072
[pagetsitdone.com, retrieved 2026] Founder story featuring Parcel Health and Tully Tube | https://pagetsitdone.com/melinda-su-en-lee/
[Signalbase, retrieved 2026] Parcel Health company profile | https://www.signalbase.ai/company/parcel-health
[McLaren Health Care News] Karmanos Cancer Institute rolls out Tully Tube as standard prescription vial across pharmacy operations | https://www.mclaren.org/main/news/karmanos-cancer-institute-rolls-out-tully-tube-as-standard-prescription-vial-across-pharmacy-operations-5962
Articles about Parcel Health
- Parcel Health Is Replacing the Plastic Pill Bottle With a Paper Tube — The Pittsburgh startup's regulatory-compliant packaging is now in use at systems like Wellstar and Karmanos, targeting a massive source of medical waste.